Vascular restoration therapy and bioresorbable vascular scaffold

Regenerative Biomaterials
Yunbing Wang, Xingdong Zhang

Abstract

This article describes the evolution of minimally invasive intervention technologies for vascular restoration therapy from early-stage balloon angioplasty in 1970s, metallic bare metal stent and metallic drug-eluting stent technologies in 1990s and 2000s, to bioresorbable vascular scaffold (BVS) technology in large-scale development in recent years. The history, the current stage, the challenges and the future of BVS development are discussed in detail as the best available approach for vascular restoration therapy. The criteria of materials selection, design and processing principles of BVS, and the corresponding clinical trial results are also summarized in this article.

References

Jul 12, 1979·The New England Journal of Medicine·A R GrüntzigW E Siegenthaler
Aug 12, 1976·The New England Journal of Medicine·R Ross, J A Glomset
Jul 25, 2000·Circulation·A Colombo, E Karvouni
Jan 5, 2001·Current Cardiology Reports·V G Khurana, Z S Katusic
Jun 7, 2002·The New England Journal of Medicine·Marie-Claude MoriceUNKNOWN RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patie
Mar 8, 2003·International Journal of Cardiovascular Interventions·Takafumi TsujiHiromu Uehata
Sep 4, 2004·Coronary Artery Disease·Renu VirmaniFrank D Kolodgie
Nov 18, 2004·Journal of Interventional Cardiology·Carlo Di MarioRaimund Erbel
Feb 3, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Patrick PeetersBernd Heublein
Sep 27, 2005·Biomaterials·Subbu S VenkatramanXintong Wang
Feb 3, 2006·The New England Journal of Medicine·Patrick W SerruysAndrew T L Ong
Mar 18, 2006·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·L P TanFreddy Y C Boey
Jun 13, 2006·Biomaterials·Matthias PeusterChristian von Schnakenburg
Dec 2, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·John A OrmistonGuy Armstrong
Dec 26, 2006·Biomaterials·Gopinath ManiC Mauli Agrawal
Dec 30, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Junbo GeXuebo Liu
Feb 24, 2007·Vascular Health and Risk Management·Thein Htay, Ming W Liu
Jun 5, 2007·Lancet·Raimund ErbelUNKNOWN PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators
Dec 19, 2007·Journal of Interventional Cardiology·Ron WaksmanFermin O Tio
Jul 29, 2008·American Heart Journal·Sunil V RaoMitchell W Krucoff
Dec 25, 2008·Expert Review of Medical Devices·Gaku NakazawaRenu Virmani
Feb 26, 2009·Expert Opinion on Drug Delivery·Joanna J WykrzykowskaPatrick W Serruys
Aug 6, 2009·Acta Biomaterialia·Michael SchinhammerPeter J Uggowitzer
Nov 28, 2009·Acta Biomaterialia·Hendra HermawanDiego Mantovani
Dec 25, 2009·Circulation. Cardiovascular Interventions·John A Ormiston, Patrick W S Serruys
Sep 10, 2010·Journal of the American College of Cardiology·Scot Garg, Patrick W Serruys
Dec 15, 2009·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Ahmed A Khattab, Stephan Windecker
Dec 15, 2009·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Joanna J WykrzykowskaPatrick W Serruys
Mar 17, 2012·Expert Review of Medical Devices·Salvatore BrugalettaPatrick W Serruys

❮ Previous
Next ❯

Citations

Oct 7, 2015·Annals of Biomedical Engineering·Sean S MooreFrancesco Verdecchia
Aug 3, 2016·Regenerative Biomaterials·Tao HuangYong Han
Oct 5, 2016·Regenerative Biomaterials·Hao ZhangYunbing Wang
Mar 23, 2017·Advanced Healthcare Materials·Santosh K MisraDipanjan Pan
Nov 9, 2018·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Song LinGuixue Wang
Apr 7, 2019·Journal of Biomaterials Applications·Raasti NaseemSyed Hossainy
Jan 13, 2016·Macromolecular Bioscience·Kai WangDeling Kong
Nov 9, 2019·Biomaterials Science·Paula MajewskaMarcin Sobczak
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Raasti NaseemKenny Dalgarno

❮ Previous
Next ❯

Methods Mentioned

BETA
percutaneous transluminal coronary angioplasty
X-ray

Software Mentioned

Reva

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.